Cargando…
PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429364/ http://dx.doi.org/10.1097/01.HS9.0000976796.54495.8a |
| _version_ | 1785090694399918080 |
|---|---|
| author | Colombatti, Raffaella Kanter, Julie Wu, Eric Clay, Leila J. Campbell, Andrew |
| author_facet | Colombatti, Raffaella Kanter, Julie Wu, Eric Clay, Leila J. Campbell, Andrew |
| author_sort | Colombatti, Raffaella |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429364 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293642023-08-17 PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE Colombatti, Raffaella Kanter, Julie Wu, Eric Clay, Leila J. Campbell, Andrew Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429364/ http://dx.doi.org/10.1097/01.HS9.0000976796.54495.8a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Colombatti, Raffaella Kanter, Julie Wu, Eric Clay, Leila J. Campbell, Andrew PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title | PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title_full | PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title_fullStr | PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title_full_unstemmed | PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title_short | PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE |
| title_sort | pb2524: trial in progress: the hibiscus-kids study, a single-arm, open-label, phase 1/2 study to evaluate the pharmacokinetics and safety of etavopivat in pediatric patients with sickle cell disease |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429364/ http://dx.doi.org/10.1097/01.HS9.0000976796.54495.8a |
| work_keys_str_mv | AT colombattiraffaella pb2524trialinprogressthehibiscuskidsstudyasinglearmopenlabelphase12studytoevaluatethepharmacokineticsandsafetyofetavopivatinpediatricpatientswithsicklecelldisease AT kanterjulie pb2524trialinprogressthehibiscuskidsstudyasinglearmopenlabelphase12studytoevaluatethepharmacokineticsandsafetyofetavopivatinpediatricpatientswithsicklecelldisease AT wueric pb2524trialinprogressthehibiscuskidsstudyasinglearmopenlabelphase12studytoevaluatethepharmacokineticsandsafetyofetavopivatinpediatricpatientswithsicklecelldisease AT clayleilaj pb2524trialinprogressthehibiscuskidsstudyasinglearmopenlabelphase12studytoevaluatethepharmacokineticsandsafetyofetavopivatinpediatricpatientswithsicklecelldisease AT campbellandrew pb2524trialinprogressthehibiscuskidsstudyasinglearmopenlabelphase12studytoevaluatethepharmacokineticsandsafetyofetavopivatinpediatricpatientswithsicklecelldisease |